(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Imaging Biometrics Ltd on Friday reported positive study results for IB Neuro, and detailed its commercialisation strategy for the platform. Read More
(Alliance News) - Stock prices in Europe were higher at midday Friday, while investors digested weaker eurozone growth data and looked ahead to key US labour market figures. Read More
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Imaging Biometrics Ltd shares fell on Friday, after it said it will no longer proceed with an intended phase 2 trial of gallium maltolate. Read More
(Alliance News) - Imaging Biometrics Ltd on Wednesday said it has expanded its global distribution agreement with GE Healthcare Technologies Inc to widen access to two of its advanced neuroimaging products, FTB Express and QSMetric. Read More
(Alliance News) - Imaging Biometrics Ltd on Thursday noted the use of its Functional Tumor Burden mapping technology in a glioblastoma clinical trial at Cooper University's MD Anderson Cancer Center. Read More
(Alliance News) - Imaging Biometrics Ltd on Monday said it has successfully completed the phase one trial evaluating oral gallium maltolate for the treatment of recurrent or relapsed glioblastoma. Read More
